Orion OYJ (OTCMKTS:ORINY) Sets New 12-Month High – Time to Buy?

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s stock price hit a new 52-week high during trading on Friday. The stock traded as high as $47.6750 and last traded at $47.6750, with a volume of 195 shares trading hands. The stock had previously closed at $46.00.

Orion OYJ Stock Up 3.6%

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.64 and a quick ratio of 1.48. The company has a market capitalization of $13.46 billion, a P/E ratio of 19.62 and a beta of 0.08. The company has a 50 day moving average of $44.30 and a 200-day moving average of $40.59.

Orion OYJ (OTCMKTS:ORINY) last released its quarterly earnings results on Friday, July 17th. The company reported $0.58 EPS for the quarter. Orion OYJ had a return on equity of 50.37% and a net margin of 28.52%.The business had revenue of $606.38 million during the quarter.

About Orion OYJ

Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.

The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.

Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.